Castle Biosciences (CSTL) EBIT Margin Growth (3y) (2021 - 2026)
Castle Biosciences (CSTL) EBIT Margin Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -2,915.00 |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 233.00 |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | -292.00 |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 63.00 |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | -56.00 |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 4,378.00 |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | -51.00 |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 2,504.00 |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | -300.00 |
| 10 | Castle Biosciences | 629.76 Mn | 368.04 Mn | 63.15 Mn | 5,299.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,299.00 |
| Dec 31, 2025 | 5,516.00 |
| Sep 30, 2025 | 4,999.00 |
| Jun 30, 2025 | 647.00 |
| Mar 31, 2025 | 5,956.00 |
| Dec 31, 2024 | 6,528.00 |
| Sep 30, 2024 | 5,625.00 |
| Jun 30, 2024 | 4,447.00 |
| Mar 31, 2024 | 1,128.00 |
| Dec 31, 2023 | 897.00 |
| Sep 30, 2023 | 996.00 |
| Jun 30, 2023 | -3,712.00 |
| Mar 31, 2023 | -8,093.00 |
| Dec 31, 2022 | -7,437.00 |
| Sep 30, 2022 | -8,817.00 |
| Jun 30, 2022 | -1,706.00 |
| Mar 31, 2022 | -8,761.00 |
| Dec 31, 2021 | -10,227.00 |
| Sep 30, 2021 | 2,650.00 |
| Jun 30, 2021 | 2,830.00 |